124 related articles for article (PubMed ID: 26360303)
1. Optimization, in vitro cytotoxicity and penetration capability of deformable nanovesicles of paclitaxel for dermal chemotherapy in Kaposi sarcoma.
Pathak K; Sharma V; Sharma M
Artif Cells Nanomed Biotechnol; 2016 Nov; 44(7):1671-83. PubMed ID: 26360303
[TBL] [Abstract][Full Text] [Related]
2. Experimental design and optimization of raloxifene hydrochloride loaded nanotransfersomes for transdermal application.
Mahmood S; Taher M; Mandal UK
Int J Nanomedicine; 2014; 9():4331-46. PubMed ID: 25246789
[TBL] [Abstract][Full Text] [Related]
3. Preparation and optimization of fisetin loaded glycerol based soft nanovesicles by Box-Behnken design.
Moolakkadath T; Aqil M; Ahad A; Imam SS; Praveen A; Sultana Y; Mujeeb M
Int J Pharm; 2020 Mar; 578():119125. PubMed ID: 32036010
[TBL] [Abstract][Full Text] [Related]
4. QbD-Optimized, Phospholipid-Based Elastic Nanovesicles for the Effective Delivery of 6-Gingerol: A Promising Topical Option for Pain-Related Disorders.
Ghazwani M; Alqarni MH; Hani U; Alam A
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373129
[TBL] [Abstract][Full Text] [Related]
5. Improving Dermal Delivery of Rose Bengal by Deformable Lipid Nanovesicles for Topical Treatment of Melanoma.
Demartis S; Rassu G; Murgia S; Casula L; Giunchedi P; Gavini E
Mol Pharm; 2021 Nov; 18(11):4046-4057. PubMed ID: 34554752
[TBL] [Abstract][Full Text] [Related]
6. Development of transethosomes formulation for dermal fisetin delivery: Box-Behnken design, optimization, in vitro skin penetration, vesicles-skin interaction and dermatokinetic studies.
Moolakkadath T; Aqil M; Ahad A; Imam SS; Iqbal B; Sultana Y; Mujeeb M; Iqbal Z
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):755-765. PubMed ID: 29730964
[TBL] [Abstract][Full Text] [Related]
7. Fisetin loaded binary ethosomes for management of skin cancer by dermal application on UV exposed mice.
Moolakkadath T; Aqil M; Ahad A; Imam SS; Praveen A; Sultana Y; Mujeeb M; Iqbal Z
Int J Pharm; 2019 Apr; 560():78-91. PubMed ID: 30742987
[TBL] [Abstract][Full Text] [Related]
8. Nanovesicles for transdermal delivery of felodipine: Development, characterization, and pharmacokinetics.
Yusuf M; Sharma V; Pathak K
Int J Pharm Investig; 2014 Jul; 4(3):119-30. PubMed ID: 25126525
[TBL] [Abstract][Full Text] [Related]
9. Sertaconazole nitrate loaded nanovesicular systems for targeting skin fungal infection: In-vitro, ex-vivo and in-vivo evaluation.
Abdellatif MM; Khalil IA; Khalil MAF
Int J Pharm; 2017 Jul; 527(1-2):1-11. PubMed ID: 28522423
[TBL] [Abstract][Full Text] [Related]
10. Development and optimization of apigenin-loaded transfersomal system for skin cancer delivery: in vitro evaluation.
Jangdey MS; Gupta A; Saraf S; Saraf S
Artif Cells Nanomed Biotechnol; 2017 Nov; 45(7):1452-1462. PubMed ID: 28050929
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous Optimization of Oral and Transdermal Nanovesicles for Bioavailability Enhancement of Ivabradine Hydrochloride.
Naguib MJ; Elsayed I; Teaima MH
Int J Nanomedicine; 2021; 16():2917-2931. PubMed ID: 33911861
[TBL] [Abstract][Full Text] [Related]
12. Design, optimization, and characterization of
Albratty M
J Biomater Sci Polym Ed; 2023 Dec; 34(17):2356-2375. PubMed ID: 37622439
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Concanavalin-A conjugated nanotransfersomal gel of apigenin for enhanced targeted delivery of UV induced skin malignant melanoma.
Jangdey MS; Kaur CD; Saraf S
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):904-916. PubMed ID: 30856018
[TBL] [Abstract][Full Text] [Related]
14. Treatment of advanced classic Kaposi's sarcoma with weekly low-dose paclitaxel therapy.
Baskan EB; Tunali S; Adim SB; Kiyici M; Ali R
Int J Dermatol; 2006 Dec; 45(12):1441-3. PubMed ID: 17184252
[No Abstract] [Full Text] [Related]
15. Terbinafine hydrochloride nanovesicular gel: In vitro characterization, ex vivo permeation and clinical investigation.
AbdelSamie SM; Kamel AO; Sammour OA; Ibrahim SM
Eur J Pharm Sci; 2016 Jun; 88():91-100. PubMed ID: 27072432
[TBL] [Abstract][Full Text] [Related]
16. Transfersomes: a novel vesicular carrier for enhanced transdermal delivery of sertraline: development, characterization, and performance evaluation.
Gupta A; Aggarwal G; Singla S; Arora R
Sci Pharm; 2012; 80(4):1061-80. PubMed ID: 23264950
[TBL] [Abstract][Full Text] [Related]
17. Management of AIDS-related Kaposi sarcoma: advances in target discovery and treatment.
Dezube BJ; Pantanowitz L; Aboulafia DM
AIDS Read; 2004 May; 14(5):236-8, 243-4, 251-3. PubMed ID: 15199854
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of transfersomes, liposomes, and niosomes for topical delivery of 5-fluorouracil to skin cancer cells: preparation, characterization, in-vitro release, and cytotoxicity analysis.
Alvi IA; Madan J; Kaushik D; Sardana S; Pandey RS; Ali A
Anticancer Drugs; 2011 Sep; 22(8):774-82. PubMed ID: 21799471
[TBL] [Abstract][Full Text] [Related]
19. Proapoptotic miltefosine nanovesicles show synergism with paclitaxel: Implications for glioblastoma multiforme therapy.
Thakur A; Joshi N; Shanmugam T; Banerjee R
Cancer Lett; 2013 Jul; 334(2):274-83. PubMed ID: 22935677
[TBL] [Abstract][Full Text] [Related]
20. Development of thermodynamically stable nanostructured lipid carrier system using central composite design for zero order permeation of econazole nitrate through epidermis.
Keshri L; Pathak K
Pharm Dev Technol; 2013; 18(3):634-44. PubMed ID: 22339250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
